Clinical trial

A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00363896

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE3

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2017-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

Aclidinium bromideDRUG · verified · RxNorm: aclidinium bromide

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

Saint PetersburgRussia12 MoscowRussia11 SofiaBulgaria4 BerlinGermany3 WarsawPoland3 BarcelonaSpain2 LondonUnited Kingdom2 PragueCzechia2 ViennaAustria2 BucharestRomania2 LodzPoland2 DebrecenHungary2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00363896 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.